Related Experiment Videos
PIK3CA mutations in glioblastoma multiforme.
Christian Hartmann1, Gesine Bartels, Claire Gehlhaar
1Department of Neuropathology, Charité, Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. ch.hartmann@charite.de
Acta Neuropathologica
|June 1, 2005
Summary
Glioblastoma multiforme (GBM) exhibits frequent PTEN mutations. PIK3CA mutations, while less common, often occur exclusively, suggesting distinct roles in glioblastoma development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Glioblastoma multiforme (GBM) is a highly aggressive brain tumor.
- Loss of chromosome 10 and PTEN gene mutations are common in GBM.
- PIK3CA mutations can affect the PI3K/Akt pathway, interacting with PTEN.
Purpose of the Study:
- To investigate the mutation frequencies of PIK3CA and PTEN in glioblastoma.
- To determine if PIK3CA and PTEN mutations occur exclusively in glioblastoma.
- To analyze mutation patterns in relation to chromosome 10 and TP53 status.
Main Methods:
- Analysis of all coding exons of PIK3CA and PTEN using single-strand conformation polymorphism and direct sequencing.
- Assessment of loss of heterozygosity on chromosome 10.
- Evaluation of TP53 mutational status in 70 glioblastoma samples.
Main Results:
- PIK3CA mutations were found in 7% of GBM cases, and PTEN mutations in 14%.
- PIK3CA mutations were concentrated in specific regions (exons 1, 9, 20), indicating mutational hotspots.
- Mutations in PIK3CA or PTEN were observed in all but one GBM, suggesting mutually exclusive alterations.
Conclusions:
- The frequency of PIK3CA mutations in glioblastoma is lower than previously suggested.
- PIK3CA and PTEN mutations likely represent distinct oncogenic events in glioblastoma development.
- Further research into the PI3K/Akt pathway in GBM is warranted.